CONNIE SCARPINE: Open Payments
NPI 1831176114 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,202 in 177 payments from 30 companies in 2025. Trend: 2023 $3,408 · 2024 $3,417 · 2025 $3,202
Food & beverage: $3,202
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $297 |
| AstraZeneca Pharmaceuticals LP | 12 | $226 |
| Novo Nordisk Inc | 12 | $221 |
| GlaxoSmithKline, LLC. | 16 | $219 |
| Otsuka America Pharmaceutical, Inc. | 18 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $179 |
| Sumitomo Pharma America, Inc. | 9 | $171 |
| Axsome Therapeutics, Inc. | 9 | $167 |
| Verona Pharma, Inc. | 7 | $158 |
| Lilly USA, LLC | 8 | $155 |
Products named: REXULTI, TRELEGY ELLIPTA, CAPLYTA, GEMTESA, Auvelity, FARXIGA, Ohtuvayre, MOUNJARO.
Industry payments across NY — which companies pay providers there.
